Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II Trial of Dose-Escalated Busulfan Delivered by Prolonged Continuous Infusion in Allogeneic Transplant Patients.
Shea TC, Walko C, Chung Y, Ivanova A, Sheets J, Rao K, Gabriel D, Comeau T, Wood W, Coghill J, Armistead P, Sarantopoulos S, Serody J. Shea TC, et al. Biol Blood Marrow Transplant. 2015 Dec;21(12):2129-2135. doi: 10.1016/j.bbmt.2015.07.016. Epub 2015 Jul 22. Biol Blood Marrow Transplant. 2015. PMID: 26210442 Free PMC article. Clinical Trial.
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies.
Shea TC, Bruner R, Wiley JM, Serody JS, Sailer S, Gabriel DA, Capel E, Moore DT, Dent G, Bentley S, Brecher ME. Shea TC, et al. Among authors: gabriel da. Biol Blood Marrow Transplant. 2003 Jul;9(7):443-52. doi: 10.1016/s1083-8791(03)00204-0. Biol Blood Marrow Transplant. 2003. PMID: 12869958 Free article. Clinical Trial.
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival.
Shea TC, Beaven AW, Moore DT, Serody JS, Gabriel DA, Chao N, Gockerman JP, Garcia RA, Rizzieri DA. Shea TC, et al. Among authors: gabriel da. Leuk Lymphoma. 2009 May;50(5):741-8. doi: 10.1080/10428190902853136. Leuk Lymphoma. 2009. PMID: 19358012 Clinical Trial.
Effectiveness of an algorithm-based approach to the utilization of plerixafor in patients undergoing chemotherapy-based stem cell mobilization.
Chow E, Rao KV, Wood WA, Covington D, Armistead PM, Coghill J, Serody JS, Gabriel DA, Jamieson KJ, Park YA, Raval JS, Shea TC. Chow E, et al. Among authors: gabriel da. Biol Blood Marrow Transplant. 2014 Jul;20(7):1064-8. doi: 10.1016/j.bbmt.2014.03.023. Epub 2014 Apr 3. Biol Blood Marrow Transplant. 2014. PMID: 24704385 Free article.
Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation.
Serody JS, Sparks SD, Lin Y, Capel EJ, Bigelow SH, Kirby SL, Gabriel DA, Wiley JM, Brecher ME, Schell MJ, Folds J, Shea TC. Serody JS, et al. Among authors: gabriel da. Biol Blood Marrow Transplant. 2000;6(4A):434-40. doi: 10.1016/s1083-8791(00)70035-8. Biol Blood Marrow Transplant. 2000. PMID: 10975512 Clinical Trial.
Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCT.
Wood WA, Whitley J, Goyal R, Brown PM, Sharf A, Irons R, Rao KV, Essenmacher A, Serody JS, Coghill JM, Armistead PM, Sarantopoulos S, Gabriel DA, Shea TC. Wood WA, et al. Among authors: gabriel da. Bone Marrow Transplant. 2013 Jun;48(6):771-6. doi: 10.1038/bmt.2012.216. Epub 2012 Nov 19. Bone Marrow Transplant. 2013. PMID: 23165501 Free PMC article.
161 results